ATI RN
Wongs Essentials of Pediatric Nursing 11th Edition Test Bank Questions
Question 1 of 5
for pain management. When applying a new system, the nurse should:
Correct Answer: B
Rationale: When applying a new system for pain management, it is recommended to choose a site on the lower torso. This area is often a suitable location for applying transdermal pain medication patches because it tends to have fewer hair follicles, making it easier for the patch to adhere properly and be absorbed effectively. The lower torso also typically provides a discreet location for patch placement, helping to maintain patient privacy and comfort.
Question 2 of 5
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents; it has multiple subtypes and requires different modalities of treatment including surgery and chemotherapy. Of the following, the subtype of osteosarcoma which is treated by surgery alone is
Correct Answer: D
Rationale: Periosteal osteosarcoma is often treated with surgery alone if margins are clear.
Question 3 of 5
Osteosarcoma is the most common primary malignant bone tumor in children and adolescents; it has multiple subtypes and requires different modalities of treatment including surgery and chemotherapy. Of the following, the subtype of osteosarcoma which is treated by surgery alone is
Correct Answer: D
Rationale: Periosteal osteosarcoma is often treated with surgery alone if margins are clear.
Question 4 of 5
Hindbrain herniation or the Chiari type II malformation is seen in which percent of individuals with myelomeningocele
Correct Answer: D
Rationale: Chiari type II malformation is strongly associated with myelomeningocele, occurring in approximately 80-90% of cases due to abnormal cerebellar development and cranial settling.
Question 5 of 5
A client with acquired immunodeficiency syndrome (AIDS) is receiving zidovudine (azidothymidine, AZT [Retrovir]). To check for adverse drug effects, the nurse should monitor the results of laboratory test?
Correct Answer: D
Rationale: Zidovudine (azidothymidine, AZT [Retrovir]) is an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection. One of the potential adverse effects of zidovudine is bone marrow suppression, which can lead to decreased production of blood cells including platelets. Monitoring the platelet count is essential because a low platelet count (thrombocytopenia) can result in an increased risk of bleeding and bruising. Therefore, regular monitoring of platelet count is crucial to detect and manage this potential adverse effect promptly in patients receiving zidovudine therapy. Monitoring other laboratory tests such as RBC count, serum calcium, and fasting blood glucose may also be important for assessing overall health status, but platelet count monitoring takes priority due to the risk of thrombocytopenia associated with zidovudine therapy.